Buy, Sell or Hold: MoonLake Immunotherapeutics (MLTX-Q)

Home

Daily Stock Opinions and Ratings

MoonLake Immunotherapeutics (MLTX-Q)

7.46

+0.40 (5.67%)

as of Oct 2, 2025, 8:00:00 pm Market Open.

1 watching

Nervous markets await Nvidia

Most recent Opinions go here

Be up to date, don’t miss your chance.

TOP PICK

Financial Highlights for MoonLake Immunotherapeutics in Q2 '25. Gross Profit stood at -740,000, marking a -96.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Cost of Revenue was 740,000, a 96.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations. Social media mentions are up 59.1% in the past 24h.

MoonLake Immunotherapeutics

Premium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

Showing 1 to 2 of 2 entries

MoonLake Immunotherapeutics(MLTX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for MoonLake Immunotherapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

MoonLake Immunotherapeutics(MLTX-Q) Frequently Asked Questions

What is MoonLake Immunotherapeutics stock symbol?

MoonLake Immunotherapeutics is a American stock, trading under the symbol MLTX-Q on the NASDAQ (MLTX). It is usually referred to as NASDAQ:MLTX or MLTX-Q

Is MoonLake Immunotherapeutics a buy or a sell?

In the last year, there was no coverage of MoonLake Immunotherapeutics published on Stockchase.

Is MoonLake Immunotherapeutics a good investment or a top pick?

MoonLake Immunotherapeutics was recommended as a Top Pick by on . Read the latest stock experts ratings for MoonLake Immunotherapeutics.

Why is MoonLake Immunotherapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is MoonLake Immunotherapeutics worth watching?

In the last year, there was no coverage of MoonLake Immunotherapeutics published on Stockchase.

What is MoonLake Immunotherapeutics stock price?

On 2025-10-02, MoonLake Immunotherapeutics (MLTX-Q) stock closed at a price of $7.46.

Most Recent Experts

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Colin Cieszynski

SIA Wealth Management

Dennis da Silva

Middlefield Capital Ltd.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.